Opportunity Information: Apply for PA 13 052
Apply for PA 13 052
- The National Institutes of Health in the food and nutrition health sector is offering a public funding opportunity titled "Technological Improvements to Data Collection in NIDDK Kidney and Urology Clinical Studies (SBIR) (R43/R44)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research.
- This funding opportunity was created on Feb 21, 2013 and posted on Dec 18, 2012.
- Applicants must submit their applications by Jan 7, 2016. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: Small businesses.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The grant opportunity titled "Technological Improvements to Data Collection in NIDDK Kidney and Urology Clinical Studies (SBIR) (R43/R44)" (Funding Opportunity Number PA 13-052) is a National Institutes of Health (NIH) Small Business Innovation Research (SBIR) solicitation aimed at improving how clinical research data are captured in studies supported by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), specifically within kidney and urology clinical research. The central purpose is to fund small businesses to design, develop, and test practical tools that make clinical study data collection more efficient, more accurate, less burdensome for participants and study staff, and better suited for modern research workflows. In plain terms, NIH was looking for companies that could build devices, software, or enabling technologies that streamline the collection of source data used in NIDDK-funded clinical studies.
This opportunity uses the SBIR phased structure under the R43/R44 mechanisms, which generally aligns with early-stage feasibility work followed by more advanced development and validation. Phase I (R43) typically supports proof-of-concept and technical feasibility, while Phase II (R44) generally supports further development, refinement, and demonstration of performance in more realistic settings, such as pilot deployments in clinical study environments. The emphasis here is not on basic science, but on research and development that produces a tangible data-collection improvement that could be adopted by clinical researchers running kidney and urology studies. The technologies could involve better ways to capture clinical measurements, patient-reported outcomes, biospecimen-related metadata, workflow-integrated data entry, remote monitoring, or other approaches that reduce errors and missingness while improving timeliness and standardization.
Administratively, this is a discretionary grant opportunity offered by NIH, with the activity tied to the NIDDK extramural research portfolio (CFDA 93.847). It is explicitly limited to eligible small business applicants, and it does not require cost sharing or matching funds, which is typical for SBIR awards. The posting date was December 18, 2012, with a creation date of February 21, 2013. The original and final closing date listed is January 7, 2016, and the opportunity was archived on February 7, 2016, meaning it is no longer open for new applications under that particular announcement. For historical reference and full details, NIH provided the FOA text through its grants policy and guidance site at http://grants.nih.gov/grants/guide/pa-files/PA-13-052.html.
From an implementation standpoint, the kinds of projects that fit this FOA are those that directly address real pain points in clinical data acquisition for kidney and urology research: incomplete or inconsistent case report forms, burdensome manual transcription, poor integration with clinical systems, difficulties capturing longitudinal outcomes, and challenges collecting high-quality data outside the clinic. Strong applications typically would have proposed a clear technical approach, a plan to validate that the tool improves data quality or efficiency, and an adoption pathway showing how the product could be used in NIDDK-supported clinical studies. NIH also provided basic contact guidance through the NIH Office of Extramural Research (OER) webmaster for access or linking issues, indicating where applicants could get help if they had trouble reaching the full electronic announcement.
Frequently Asked Questions (FAQs)
What is the title and funding opportunity number for this grant?
The opportunity is titled "Technological Improvements to Data Collection in NIDDK Kidney and Urology Clinical Studies (SBIR) (R43/R44)" and the Funding Opportunity Number is PA 13-052.
Which agency is offering this opportunity?
This is a National Institutes of Health (NIH) funding opportunity.
Which NIH institute is associated with the program focus?
The opportunity is tied to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), specifically within kidney and urology clinical research supported by NIDDK.
What is the main purpose of this SBIR solicitation?
The purpose is to fund small businesses to design, develop, and test practical tools that improve how clinical research data are captured in NIDDK-supported kidney and urology clinical studies. The goal is more efficient, more accurate, and less burdensome data collection for participants and study staff, aligned with modern research workflows.
What types of solutions was NIH looking for under this announcement?
NIH was looking for devices, software, or enabling technologies that streamline the collection of source data used in NIDDK-funded kidney and urology clinical studies.
Is this grant focused on basic science or product-oriented research and development?
The emphasis is not on basic science. It focuses on research and development intended to produce tangible improvements to clinical study data collection that could be adopted by clinical researchers conducting kidney and urology studies.
What funding mechanisms are used in this opportunity?
This opportunity uses the SBIR phased structure under the R43/R44 mechanisms.
What is the difference between Phase I (R43) and Phase II (R44) in this context?
Phase I (R43) typically supports proof-of-concept and technical feasibility. Phase II (R44) generally supports further development, refinement, and demonstration of performance in more realistic settings, such as pilot deployments in clinical study environments.
What areas of clinical data collection were highlighted as relevant?
Examples mentioned include better ways to capture clinical measurements, patient-reported outcomes, biospecimen-related metadata, workflow-integrated data entry, remote monitoring, and other approaches that reduce errors and missing data while improving timeliness and standardization.
What kinds of data-collection problems in kidney and urology studies was this intended to address?
The announcement emphasized real pain points in clinical data acquisition such as incomplete or inconsistent case report forms, burdensome manual transcription, poor integration with clinical systems, difficulties capturing longitudinal outcomes, and challenges collecting high-quality data outside the clinic.
Who is eligible to apply?
The opportunity is explicitly limited to eligible small business applicants (as an SBIR solicitation).
Is cost sharing or matching funding required?
No. The opportunity states that it does not require cost sharing or matching funds, which is typical for SBIR awards.
What is the CFDA number associated with this opportunity?
The CFDA number listed is 93.847.
What were the key dates for this funding opportunity?
The posting date was December 18, 2012. The creation date was February 21, 2013. The original and final closing date listed was January 7, 2016. The opportunity was archived on February 7, 2016.
Is this funding opportunity still open to new applications?
No. It was archived on February 7, 2016, and the final closing date listed is January 7, 2016, meaning it is no longer open under that particular announcement.
Where can someone find the full FOA text for reference?
The FOA text was provided by NIH at: http://grants.nih.gov/grants/guide/pa-files/PA-13-052.html
What characteristics were implied for a strong application?
Strong applications typically would have proposed a clear technical approach, included a plan to validate that the tool improves data quality or efficiency, and described an adoption pathway showing how the product could be used in NIDDK-supported clinical studies.
What kind of validation or testing was implied as important?
The description emphasizes designing, developing, and testing practical tools, with Phase II involving demonstration of performance in more realistic settings such as pilot deployments in clinical study environments.
Does the opportunity mention any support contact for access or linking problems?
Yes. NIH provided basic contact guidance through the NIH Office of Extramural Research (OER) webmaster for access or linking issues related to reaching the full electronic announcement.
What does it mean that this is a discretionary grant opportunity?
Based on the description provided, it is presented as a discretionary grant opportunity offered by NIH and tied to the NIDDK extramural research portfolio.
Browse more opportunities from the same category: Food and Nutrition Health
Next opportunity: RESEARCH OPPORTUNITIES IN AERONAUTICS 2013
Previous opportunity: Technological Improvements to Data Collection in NIDDK Kidney and Urology Clinical Studies (SBIR) (R41/R42)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PA 13 052
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PA 13 052) also looked into and applied for these:
| Funding Opportunity |
|---|
| Research Resource for Human Organs and Tissues (U42) Apply for RFA OD 13 002 Funding Number: RFA OD 13 002 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
| Continuation of the Clinical Centers for the Drug Induced Liver Injury Network DILIN (U01) Apply for RFA DK 13 003 Funding Number: RFA DK 13 003 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $250,000 |
| Limited Competition of the MAPP Research Network Data Coordinating Core (U01) Apply for RFA DK 13 501 Funding Number: RFA DK 13 501 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
| Silvio O. Conte Digestive Diseases Research Core Centers (P30) Apply for RFA DK 12 023 Funding Number: RFA DK 12 023 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $750,000 |
| Small Grants for New Investigators to Promote Diversity in Health Related Research (R03) Apply for PAR 13 074 Funding Number: PAR 13 074 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $125,000 |
| Improvement of Animal Models for Stem Cell Based Regenerative Medicine (R01) Apply for PAR 13 114 Funding Number: PAR 13 114 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
| Undergraduate Summer Institutes in Kidney, Urologic and Hematologic Diseases (R25) Apply for RFA DK 13 005 Funding Number: RFA DK 13 005 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
| Acute Kidney Injury in Older Adults (R01) Apply for PA 13 141 Funding Number: PA 13 141 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
| Addressing Health Disparities in NIDDK Diseases (R01) Apply for PA 13 183 Funding Number: PA 13 183 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
| Planning Grants for Translating CKD Research into Improved Clinical Outcomes (R34) Apply for RFA DK 13 002 Funding Number: RFA DK 13 002 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $225,000 |
| Biomarkers for Diabetes, Digestive, Kidney and Urologic Diseases Using Biosamples from the NIDDK Repository (R01) Apply for PAR 13 228 Funding Number: PAR 13 228 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $250,000 |
| United States Renal Data System (USRDS) Special Study Centers (U01) Apply for RFA DK 13 008 Funding Number: RFA DK 13 008 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
| Type 1 Diabetes TrialNet Clinical Network Hub (U01) Apply for RFA DK 13 009 Funding Number: RFA DK 13 009 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $2,000,000 |
| Type 1 Diabetes TrialNet Clinical Centers (U01) Apply for RFA DK 13 010 Funding Number: RFA DK 13 010 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $200,000 |
| NIDDK Program Projects (P01) Apply for PAR 13 266 Funding Number: PAR 13 266 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
| NIDDK Multi Center Clinical Study Implementation Planning Cooperative Agreements (U34) Apply for PAR 13 268 Funding Number: PAR 13 268 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $225,000 |
| Limited Competition for the Continuation of a National Endoscopic Database (U01) Apply for RFA DK 13 504 Funding Number: RFA DK 13 504 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
| Diabetes Research Centers (P30) Apply for RFA DK 13 004 Funding Number: RFA DK 13 004 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
| Continuation of ChiLDReN, the Childhood Liver Disease Research Network (U01) Apply for RFA DK 13 011 Funding Number: RFA DK 13 011 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
| Limited Competition Continuation of the Nonalcoholic Steatohepatitis Clinical Research Network (NASH CRN)(U01) Apply for RFA DK 13 503 Funding Number: RFA DK 13 503 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PA 13 052", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.